---
title: 'The biological significance of tumor grade, age, enhancement and extent of
  resection in IDH mutant gliomas: how should they inform treatment decision in the
  era of IDH inhibitors? Invited review'
date: '2024-06-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38912846/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240624182446&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: The 2016 and 2021 World Health Organization (WHO) 2021 Classification
  of Central Nervous System (CNS) tumors have resulted in a major improvement of the
  classification of IDH-mutant gliomas. With more effective treatments many patients
  experience prolonged survival . However, treatment guidelines are often still based
  on information from historical series comprising both patients with IDHwt and IDH
  mutant tumors. They provide recommendations for radiotherapy and chemotherapy for
  ...
disable_comments: true
---
The 2016 and 2021 World Health Organization (WHO) 2021 Classification of Central Nervous System (CNS) tumors have resulted in a major improvement of the classification of IDH-mutant gliomas. With more effective treatments many patients experience prolonged survival . However, treatment guidelines are often still based on information from historical series comprising both patients with IDHwt and IDH mutant tumors. They provide recommendations for radiotherapy and chemotherapy for ...